EXHIBIT 31.1

   CERTIFICATION REQUIRED BY SECTION 302(A) OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph Frattaroli, certify that:

         1.   I have reviewed this Quarterly Report on Form 10-QSB of Vaso
              Active Pharmaceuticals, Inc.;

         2.   Based on my knowledge, this report does not contain any untrue
              statement of a material fact or omit to state a material fact
              necessary to make the statements made, in light of the
              circumstances under which such statements were made, not
              misleading with respect to the period covered by this report;

         3.   Based on my knowledge, the financial statements, and other
              financial information included in this report, fairly present in
              all material respects the financial condition, results of
              operations and cash flows of the small business issuer as of, and
              for, the periods presented in this report;

         4.   The small business issuer's other certifying officer(s) and I are
              responsible for establishing and maintaining disclosure controls
              and procedures (as defined in Exchange Act Rules 13a-15(e) and
              15d-15(e)) for the small business issuer and have:

                   (a)  Designed such disclosure controls and procedures, or
                        caused such disclosure controls and procedures to be
                        designed under our supervision, to ensure that material
                        information relating to the small business issuer is
                        made known to us by others within those entities,
                        particularly during the period in which this report is
                        being prepared;

                   (b)  Evaluated the effectiveness of the small business
                        issuer's disclosure controls and procedures and
                        presented in this report our conclusions about the
                        effectiveness of the disclosure controls and procedures,
                        as of the end of the period covered by this report based
                        on such evaluation; and

                   (c)  Disclosed in this report any change in the small
                        business issuer's internal control over financial
                        reporting that occurred during the small business
                        issuer's most recent fiscal quarter (the small business
                        issuer's fourth fiscal quarter in the case of an annual
                        report) that has materially affected, or is reasonably
                        likely to materially affect, the small business issuer's
                        internal control over financial reporting; and

         5.   The small business issuer's other certifying officer(s) and I have
              disclosed, based on our most recent evaluation of internal control
              over financial reporting, to the small business issuer's auditors
              and the audit committee of the small business issuer's board of
              directors (or persons performing the equivalent functions):

                   (a)  All significant deficiencies and material weaknesses in
                        the design or operation of internal control over
                        financial reporting which are reasonably likely to
                        adversely affect the small business issuer's ability to
                        record, process, summarize and report financial
                        information; and

                   (b)  Any fraud, whether or not material, that involves
                        management or other employees who have a significant
                        role in the small business issuer's internal control
                        over financial reporting.

August 22, 2005

By: /s/ Joseph Frattaroli
Acting Chief Executive Officer (principal executive officer)
Chief Financial Officer (principal financial officer)